Annals of Family Medicine

NOVEMBER 20, 2024

Population studied: This review includes English and Persian articles (1806-2023) focusing on the impacts of infectious crises on family physicians' mental health in diverse primary care settings (e.g. long-term nursing homes, clinics), highlighting their perceived needs.

Family Physician 130

Family Physician Mental Health Family Families 130

Integrated Care News by CFHA

MAY 19, 2025

MBC is presented not simply as data collection, but as a dynamic, evidence-based clinical process that enhances outcomes, promotes equity, and strengthens team-based care. MBC supports optimal clinical practice, demonstrates the value of integrated care teams, and improves outcomes. What is MBC? 3, 4) Why is MBC important? 1, 8, 9) d.

Integrated Care 100

Integrated Care Mental Health Healthcare Clinical Practice 100

The Medical Futurist

JUNE 19, 2025

Determining patients’ prognosis Due to individual variations in genetics and lifestyle choices, each person ages at a different rate. However, this visual assessment can be impaired by individual biases, thereby impacting objective care decisions. FaceHeart also received FDA approval for the heart rate component in 2023.

Individual 96

Individual Clinic Medical Patients 96

The Clinical Problem Solvers

JUNE 26, 2023

[link] CPSolvers: Anti-Racism in Medicine Series Episode 22 – Live from SGIM 2023: Best of Antiracism Research at the Society of General Internal Medicine’s 2023 Annual Meeting Show Notes by Alec J. Following residency, she was a Robert Wood Johnson Clinical Scholar and received health services research methodology training.

Electronics 52

Electronics Internal Medicine Patient-Centered Healthcare 52

Physician's Weekly

JUNE 13, 2025

An expert panel unveiled a preoperative cannabis use assessment tool to aid in planning informed, individualized anesthesia and analgesia patient care. An expert panel has created a preoperative cannabis use assessment tool to aid healthcare professionals in planning informed, individualized anesthesia and analgesia care for patients.

Clinical Practice 52

Clinical Practice Healthcare Professional Healthcare Experience Screening 52

Physician's Weekly

JUNE 22, 2025

Notable gains were also seen in the NYHA functional class and NT-proBNP levels in 1 year. Investigators concluded that semaglutide significantly improved health status and mood in individuals with HF and obesity, with these benefits closely associated with weight loss.

Individual 52

Individual Diabetes Hospital Clinic 52

Annals of Family Medicine

NOVEMBER 20, 2024

Instrument/Dataset: Ten item subset within the 2023 Council of Academic Family Medicine’s (CAFM) Educational Research Alliance (CERA) survey, administered from Nov.20-Dec.22, Study Design and Analysis: Cross-sectional survey. POPULATION STUDIED: U.S.

Healthcare 130

Healthcare Family Medicine DO Healthcare Professional 130

The Clinical Problem Solvers

DECEMBER 16, 2020

Nwamaka Eneanya and Jennifer Tsai to discuss the limitations and harms of race-based medicine in clinical practice. Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality.

Clinic 52

Clinic Education Clinical Practice Patient-Centered 52

Annals of Family Medicine

NOVEMBER 20, 2024

Context: The impact of the COVID-19 pandemic on individuals with schizophrenia who are admitted to academic medical centers (AMCs) has not been previously reported. from Oct 2019 to Dec 2023. Study Design: This retrospective case series analysis utilizes Vizient’s clinical database data. Setting: AMCs within the US.

Patient-Centered 130

Patient-Centered Patients Medical Illness 130

Annals of Family Medicine

NOVEMBER 20, 2024

Dataset: We used data routinely collected through the CPSMP between December 2017 and May 2023. Population studied: The CPSMP targeted individuals suffering from chronic pain in the Champlain region of Eastern Ontario. The number of participants peaked in 2018 and remained stable thereafter.

Management 130

Management Utilities Referral Individual 130

Annals of Family Medicine

NOVEMBER 20, 2024

Context: Traditional clinical health datasets often fail to represent the diversity and breadth of real-world disease, influencing research and AI tools developed on those datasets. Study Design and Analysis: We employed Google Search ads to gather dermatology images from the public, with informed consent, between March and November 2023.

Education 130

Education Community Individual Clinic 130

Annals of Family Medicine

NOVEMBER 20, 2024

Objective: To examine the impact of discontinuation of statins compared to continuation on clinical outcomes. We searched MEDLINE, Embase, Cochrane Central Registry of Trials (inception to August 2023). Our findings underscore the need for RCT evidence in appropriately selected individuals, to guide clinical decision-making.

Screening 130

Screening Clinic Individual Provider 130

Annals of Family Medicine

NOVEMBER 20, 2024

Instrument: An online survey was distributed, and subsequent semi-structured telephone or video interviews were conducted between May and December 2023. Results: 102 individuals completed the on-line survey and of those, 19 participated in the interviews (13 parents and six primary care providers).

Primary Care 130

Primary Care Provider Finance Healthcare 130

My Green Doctor

APRIL 4, 2025

According to the 2023 report of the Lancet Countdown, mortality caused by extreme heat events increased by 53.7% It tells your office colleagues and patients that your healthcare practice or clinic is committed to forging a healthier work space and community. from 2000 to 2018 among people over 65 years old. Let’s talk!

Healthcare Professional 52

Healthcare Professional Healthcare Community Medical Advice 52

FDA Law Blog

MAY 4, 2023

Cato — On May 2nd, FDA released a new draft guidance with recommendations for decentralized clinical trials (DCTs) for drugs, biologics, and devices. In a DCT, trial-related activities may occur in trial participants’ homes, at local health care providers’ offices, or in local clinical laboratories.

Clinic 59

Clinic Telehealth Provider Electronics 59

Medical Xpress

APRIL 18, 2023

Among individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for hereditary breast and ovarian cancer (HBOC) or Lynch syndrome, 39.2%

Screening 71

Screening Individual Clinic 71

The Clinical Problem Solvers

APRIL 3, 2023

[link] CPSolvers: Anti-Racism in Medicine Series Episode 20 – Medical Racism and Indigenous Peoples Show Notes by Sudarshan (“Sud”) Krishnamurthy April 4, 2023 Summary: This episode highlights the checkered past of medicine and the advancements in the field that have occurred at the expense of the humanity of Indigenous peoples.

Medical 52

Medical Healthcare Individual Community 52

FDA Law Blog

SEPTEMBER 20, 2021

When FDA published the fiscal years (FY) 2023-2027 goals letter at the end of August, making known their commitments and planned initiatives for the coming years, we were both excited by many of the announcements, while recognizing the real success will come from how the Agency implements them.

Patient-Centered 52

Patient-Centered Manufacturing Clinic Provider 52

FDA Law Blog

JULY 17, 2024

This individual will play a key role in overseeing the new integrated Hub model and helping to develop and implement its strategic agenda action plan. clinical pharmacology/biomarkers, animal models, real-world evidence and other externally controlled comparisons [e.g.,

Patient-Centered 105

Patient-Centered Community Medical Specialty Clinic 105

PEMBlog

MAY 1, 2025

In this episode, we tackle the clinical mischief of Parvovirus B19 , a common viral infection with a surprisingly wide range of manifestationsfrom the classic slapped cheek rash of erythema infectiosum to aplastic crises in children with hemolytic anemias and fetal hydrops in pregnant contacts. link] Edwards, Morven S. UpToDate , Jun.

Complication 83

Complication Patient-Centered Patients Clinic 83

FDA Law Blog

SEPTEMBER 19, 2023

That Policy Statement , issued on September 14, 2023, warns companies that improper listing of patents in the Orange Book could be “ an unfair method of competition in violation of the FTC Act ”. The six-page statement explains that “Brand drug manufacturers may be harming generic competition through the improper listing of patents in the.

Manufacturing 105

Manufacturing Provider IT Healthcare 105

FDA Law Blog

JUNE 22, 2023

FDA hailed its authorization of the Lucira OTC home test for influenza and COVID-19 as “underscor[ing] the Agency’s continued commitment to increase availability of accurate and reliable at-home diagnostic tests” ( April 2023 FDA Update to CDC ). lay users). seeking treatment).

Manufacturing 59

Manufacturing Clinic IT Transportation 59

FDA Law Blog

JUNE 21, 2023

Cato — On June 1, CDRH announced that it is seeking public comment on questions regarding how CDRH can facilitate access to medical technologies designed for use outside of traditional clinical settings, particularly in the home. What medical technologies could be ideal to transition to use in non-clinical settings?

Medical 45

Medical Patients Healthcare Electronics 45

FDA Law Blog

MARCH 8, 2023

By Véronique Li, Senior Medical Device Regulation Expert — On March 17, 2023, enhancements to FDA’s electronic Medical Device Reporting (eMDR) system will go live. Test deployment for the changes listed above were deployed to eMDR on August 19, 2022 and will be deployed to production on March 17, 2023.

Electronics 59

Electronics Manufacturing Provider Medical 59

FDA Law Blog

FEBRUARY 23, 2025

Such assessments are highly individualized and difficult to map onto the few examples provided by FDA in its guidance. For example, in an October 13, 2023 WL to ReNovo, Inc., Manufacturers should, therefore, welcome any additional source of examples of device changes to aid in evaluating their own.

Manufacturing 64

Manufacturing Provider Consulting IT 64

FDA Law Blog

MAY 8, 2023

In addition, manufacturers should identify whether the modifications will apply to all devices in the field (referred to as global adaptations) or will be implemented based on a specific clinical site or individual patients” (referred to as local adaptations).

Manufacturing 98

Manufacturing Provider Medical IT 98

FDA Law Blog

OCTOBER 2, 2023

The eagerly anticipated guidance, Demonstrating Substantial Evidence of Effectiveness With One Adequate and Well-Controlled Clinical Investigation and Confirmatory Evidence (i.e., In contrast, the new September 2023 Confirmatory Evidence Guidance is dedicated solely to the single study plus confirmatory evidence pathway.

IT 64

IT Clinic Provider Medical 64

PEMBlog

SEPTEMBER 6, 2023

Laboratory evaluation should be based on individual patient history and exam. We need to choose wisely and act prudently for our patients, as individual practitioners and as accepting inpatient psychiatric facilities. Hosp Pediatr (2023) 13 (1): 66–71 2015;34(5):812-818 Chun TH. Ann Emerg Med. Ann Emerg Med. 2014;63(6):666-675.e663.

Lab Testing 52

Lab Testing Medical Patients Mental Health 52

FDA Law Blog

APRIL 23, 2023

This Draft Guidance focuses on the use of patient-level data from other clinical trials or from RWD sources. The Draft Guidance recommends that, where possible, the outcome should be assessed by individuals blinded to treatment status, which may require re-adjudication of externally controlled data.

Patient-Centered 49

Patient-Centered Clinic Patients Provider 49

PEMBlog

OCTOBER 18, 2024

The condition affects multiple organ systems—muscular, cardiac, and respiratory—leading to a myriad of clinical complications. Always review the latest care plans, assess longitudinal trends in cardiac biomarkers, and consult with specialists when needed to ensure that each patient receives individualized and optimal care. Pediatrics.

Patients 52

Patients Complication Management Consulting 52

FDA Law Blog

MAY 19, 2023

analytical, clinical and stability). Serial testing was defined as testing symptomatic individuals twice over three days with at least 48 hours between tests, which is in accordance with study findings from the National Institute of Health referenced here and current EUA labeling for serial testing.

Specialization 40

Specialization Clinic Provider IT 40

FDA Law Blog

NOVEMBER 2, 2023

Lewis, Senior Regulatory Device & Biologics Expert — On October 20, 2023, FDA announced the availability of the final guidance authored by CBER titled “Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies.” Tobolowsky & Richard A. It finalized a draft guidance published in 2022.

Provider 59

Provider Screening IT Government 59

GeriPal

NOVEMBER 9, 2023

Hot off the presses RCT in JAMA October 2023: Study that looks at 1000 female resident physicians at 26 sites that showed that coaching improved each outcome assessed (burnout, moral injury, imposter syndrome, self-compassion, and flourishing). AlexSmithMD 1. How much drive do you have? What does it mean to you?” Greg: Yeah, there is.

Board-Certified 110

Board-Certified IT Primary Care Referral 110

FDA Law Blog

JUNE 27, 2024

After issuing an Order to Show Cause and Immediate Suspension of Registration in September 2022, and an administrative hearing in March 2023, DEA adopted the hearing Administrative Law Judge’s (“ALJ’s”) Recommended Decision to revoke Coconut Grove’s registration based on the public interest factors of 21 U.S.C. 21 C.F.R. §§ 1306.04(a),

Insurance 52

Insurance Patients Utilities Chronic Condition 52

Common Sense Family Doctor

MAY 30, 2025

A 2023 Cochrane for Clinicians article found similar benefits but also noted that for every 10,000 people screened, 363 unnecessary invasive tests are performed.

Primary Care 59

Primary Care Screening Family Physician DO 59

Physician's Weekly

JUNE 22, 2025

High social risk burden in adults with IBD drives emergency care use and medication gaps—spotlighting the urgent need for social screening in clinical practice.

Healthcare 52

Healthcare Transportation IT Insurance 52

Today's Hospitalist

JUNE 7, 2025

They presented a rapid clinical update Webinar in May 2025 hosted by the Society of Hospital Medicine. ” All anti-obesity medications, even the earlier generation of these drugs—which include orlistat, phentermine, phentermine/topiramate (Qsymia) and naltrexone/bupropion (Contrave)—cause clinically significant weight loss.

Hospital 66

Hospital Management Diabetes Patients 66